Skip to main content

Table 7 Comparison of drug to avoid based on match between drug’s side effect profile and patients’ rankinga

From: Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer

Drug to avoid

FIRST Interview

n = 167b (%)

LAST Interview

n = 166b (%)

Drug A

56 (33.5)

42 (25.3)

Drug B

71 (42.5)

82 (49.4)

Drug C

26 (15.6)

25 (15.1)

Drug D

14 (8.4)

17 (10.2)

  1. aexcludes those who did not complete at least 2 interviews
  2. bexcludes those who did not complete the Ranking Exercise section
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us